Evidence map›Paper›PMID 24348518›Full record

ReviewFrontiers in genetics2013

Discovering epistasis in large scale genetic association studies by exploiting graphics cards.

Gary K Chen, Yunfei Guo

Abstract readReview
In one paragraph

Review in Frontiers in genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gary K ChenDivision of Biostatics, Department of Preventive Medicine, University of Southern California Los Angeles, CA, USA.
Yunfei GuoDivision of Biostatics, Department of Preventive Medicine, University of Southern California Los Angeles, CA, USA ; Zilkha Neurogenetic Institute, University of Southern California Los Angeles, CA, USA.

Funding

STATISTICAL METHODS FOR GENE MAPPINGR01GM053275 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LANGE, KENNETH L · 1995 to 2019
$9.3M
Genomics, GPUs, and Next Generation Computational StatisticsR01HG006139 · NHGRI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SOBEL, ERIC · 2011 to 2023
$5.1M
Methods for Pathway Modeling with Application to FolateR01ES019876 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMAS, DUNCAN C. · 2010 to 2014
$2.9M
Drosophila Societies: Agent-Based Analysis of Behavioral Plasticity and GeneticsR01MH100879 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MARJORAM, PAUL, NUZHDIN, SERGEY V · 2013 to 2016
$2.0M
Integrated variation detection annotation and analysis for high-throughout sequeR01HG006465 · NHGRI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI WANG, KAI · 2012 to 2016
$1.8M
NHGRI NIH HHS R01 HG006139NHGRI NIH HHS R01 HG006465NIEHS NIH HHS R01 ES019876NIGMS NIH HHS R01 GM053275NIMH NIH HHS R01 MH100879
6 · The paper itself

Abstract

Despite the enormous investments made in collecting DNA samples and generating germline variation data across thousands of individuals in modern genome-wide association studies (GWAS), progress has been frustratingly slow in explaining much of the heritability in common disease. Today's paradigm of testing independent hypotheses on each single nucleotide polymorphism (SNP) marker is unlikely to adequately reflect the complex biological processes in disease risk. Alternatively, modeling risk as an ensemble of SNPs that act in concert in a pathway, and/or interact non-additively on log risk for example, may be a more sensible way to approach gene mapping in modern studies. Implementing such analyzes genome-wide can quickly become intractable due to the fact that even modest size SNP panels on modern genotype arrays (500k markers) pose a combinatorial nightmare, require tens of billions of models to be tested for evidence of interaction. In this article, we provide an in-depth analysis of programs that have been developed to explicitly overcome these enormous computational barriers through the use of processors on graphics cards known as Graphics Processing Units (GPU). We include tutorials on GPU technology, which will convey why they are growing in appeal with today's numerical scientists. One obvious advantage is the impressive density of microprocessor cores that are available on only a single GPU. Whereas high end servers feature up to 24 Intel or AMD CPU cores, the latest GPU offerings from nVidia feature over 2600 cores. Each compute node may be outfitted with up to 4 GPU devices. Success on GPUs varies across problems. However, epistasis screens fare well due to the high degree of parallelism exposed in these problems. Papers that we review routinely report GPU speedups of over two orders of magnitude (>100x) over standard CPU implementations.

Indexed as

CUDA tutorialepistasisgene–gene interactionsGPU programminghigh performance computing

Identifiers

PMID24348518
PMCPMC3848199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.